HALO Competitors & Alternatives
Compare Halozyme Therapeutics Inc with similar stocks in the same industry
Biotechnology
HALO
Main Stock$107.20
Tradestie Score
48
Market Cap
$8.77B
P/E Ratio
31.5
Revenue Growth
0.5%
Analyst Upside
-7.1%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NBIX
Neurocrine Biosciences Inc
|
$156.22
|
$13.59B | 22.7 | 60 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$263.52
|
$12.36B | 20.1 | 47 | Compare |
|
EXEL
Exelixis Inc
|
$56.12
|
$11.09B | 18.3 | 41 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$40.82
|
$10.76B | - | 39 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$143.97
|
$10.74B | - | 39 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$65.68
|
$10.53B | 177.1 | 58 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$54.21
|
$10.49B | - | 50 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$72.44
|
$10.22B | - | 57 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$534.49
|
$10.01B | - | 50 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.12
|
$9.33B | 62.1 | 51 | Compare |
More HALO Analysis
Data updated: Sep 11, 2026 | Industry: Biotechnology (SIC 2836)
234 stocks in this industry